I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
El Hajbi, F.
26
results:
Search for persons
X
Format
Online (26)
Mediatypes
Articles (Online) (13)
OpenAccess-fulltext (13)
Sorted by: Relevance
Sorted by: Year
?
1
Tislelizumab versus chemotherapy as second-line treatment f..:
Ajani, J.
;
El Hajbi, F.
;
Cunningham, D.
...
ESMO Open. 9 (2024) 1 - p. 102202 , 2024
Link:
https://doi.org/10.1016/..
?
2
398P Nivolumab (NIVO) plus chemotherapy (chemo) or ipilimum..:
Adenis, A.
;
Chau, I.
;
Ajani, J.A.
...
Annals of Oncology. 35 (2024) - p. S161-S162 , 2024
Link:
https://doi.org/10.1016/..
?
3
Esophageal cancer - French intergroup clinical practice gui..:
Veziant, Julie
;
Bouché, Olivier
;
Aparicio, T.
...
Digestive and Liver Disease. 55 (2023) 12 - p. 1583-1601 , 2023
Link:
https://doi.org/10.1016/..
?
4
RWD123 Real-World Data About Treatment Pattern and Outcomes..:
Piessen, G
;
Adenis, A
;
Renaud, F
...
Value in Health. 25 (2022) 12 - p. S473 , 2022
Link:
https://doi.org/10.1016/..
?
5
Continuation versus discontinuation of first-line chemother..:
Adenis, A.
;
Bennouna, J.
;
Etienne, P.L.
...
European Journal of Cancer. 111 (2019) - p. 12-20 , 2019
Link:
https://doi.org/10.1016/..
?
6
Bevacizumab+chemotherapy versus chemotherapy alone in elder..:
Aparicio, T.
;
Bouché, O.
;
Taieb, J.
...
Annals of Oncology. 29 (2018) 1 - p. 133-138 , 2018
Link:
https://doi.org/10.1093/..
?
7
Geriatric analysis from PRODIGE 20 randomized phase II tria..:
Aparicio, T.
;
Bouché, O.
;
Francois, E.
...
European Journal of Cancer. 97 (2018) - p. 16-24 , 2018
Link:
https://doi.org/10.1016/..
?
8
Safety and efficacy of FOLFIRINOX in elderly patients with ..:
Baldini, C.
;
Escande, A.
;
Bouché, O.
...
Pancreatology. 17 (2017) 1 - p. 146-149 , 2017
Link:
https://doi.org/10.1016/..
?
9
2294 Growth modulation index (GMI) to assess salvage chemot..:
Ducoulombier, A.
;
Quintin, J.
;
Desjardin, M.
...
European Journal of Cancer. 51 (2015) - p. S430 , 2015
Link:
https://doi.org/10.1016/..
?
10
Prediction of Crohn's disease relapse with faecal calprotec..:
Laharie, D.
;
Mesli, S.
;
El Hajbi, F.
...
Alimentary Pharmacology & Therapeutics. 34 (2011) 4 - p. 462-469 , 2011
Link:
https://doi.org/10.1111/..
?
11
LBA46 Bevacizumab (B) plus FOLFIRI after failure of platinu..:
Walter, Thomas
;
Lievre, A
;
Coriat, R
...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.annonc.2022.08.045. , 2022
Link:
https://hal.science/hal-..
?
12
O-15 Randomized, phase 3 study of second-line tislelizumab ..:
Ajani, J
;
El Hajbi, F
;
Cunningham, D
...
boreal:273082. , 2021
Link:
http://hdl.handle.net/20..
?
13
O-15 Randomized, phase 3 study of second-line tislelizumab ..:
Ajani, J
;
El Hajbi, F
;
Cunningham, D
...
boreal:273082. , 2021
Link:
http://hdl.handle.net/20..
?
14
Continuation versus discontinuation of first-line chemother..:
Adenis, Antoine
;
Bennouna, J
;
Etienne, P.L
...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2019.01.016. , 2019
Link:
https://hal.umontpellier..
?
15
Continuation versus discontinuation of first-line chemother..:
Adenis, Antoine
;
Bennouna, J
;
Etienne, P.L
...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2019.01.016. , 2019
Link:
https://hal.umontpellier..
1-15
